Cargando…
Urinary UBC Rapid and NMP22 Test for Bladder Cancer Surveillance in Comparison to Urinary Cytology: Results from a Prospective Single-Center Study
Background: Non-muscle invasive bladder cancer (NMIBC) is associated with high rates of recurrence, resulting in frequent follow-up cystoscopies. We evaluated the use of two point-of-care tests - the nuclear matrix protein 22 (NMP22) and urinary bladder cancer antigen (UBC) Rapid - compared to routi...
Autores principales: | Pichler, Renate, Tulchiner, Gennadi, Fritz, Josef, Schaefer, Georg, Horninger, Wolfgang, Heidegger, Isabel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562188/ https://www.ncbi.nlm.nih.gov/pubmed/28824318 http://dx.doi.org/10.7150/ijms.19929 |
Ejemplares similares
-
Long term disease free survival with multimodal therapy in small cell bladder cancer
por: Heidegger, Isabel, et al.
Publicado: (2016) -
The “COVID-19 Pandemic Gap” and Its Influence on Oncologic Outcomes of Bladder Cancer
por: Tulchiner, Gennadi, et al.
Publicado: (2021) -
Adenomatoid tumor of the testis mimicking malignant testicular cancer on multiparametric ultrasound
por: Pichler, Renate, et al.
Publicado: (2018) -
Diagnostic accuracy of NMP 22 and urine cytology for detection of transitional cell carcinoma urinary bladder taking cystoscopy as gold standard
por: Sajid, Muhammad Tanveer, et al.
Publicado: (2020) -
Screening for urinary bladder cancer with the use of nuclear matrix protein (NMP) 22: is it feasible?
por: Stefanopoulos, Anastasios, et al.
Publicado: (2014)